# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
No Data found |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
With Biotest-developed Yimmugo, Grifols adds to its remarkable franchise of intravenous and subcutaneous immunoglobulins to m...
- Bloomberg
- Reuters
- Reuters
https://www.grifols.com/en/view-news/-/news/grifols-achieves-positive-results-from-phase-4-study-of-fanhdi-double-inactivated-h...
U.S. stock futures were lower this morning, with the Dow futures falling over 150 points on Thursday.